<p>Score 0 versus 1, P = .050; score 1 versus 2, P = .056; score 2 versus 3, P = .412; score 3 versus 4, P = .518; score 4 versus 5, P = .033; score 5 versus 6, P = .464. No statistical differences were noted between any scores.</p
<p>There was no statistically significant difference in the overall survival rate between caudate HC...
The clinical outcome of cirrhotic patients with hepatocellular carcinoma (HCC) depends both on the r...
Optimal scoring system for clinical prognostic factors in patients with unresectable hepatocellular ...
<p>Stage I versus II, P = .704; stage II versus III, P = .009; stage III Versus IV, P = .000. The di...
<p>Survival Curve of the Studied Sample (n = 247) (A) and overall survival curve of the HCC patients...
<p>Kaplan-Meier survival curves for patients with hepatocellular carcinoma by staging system: (A) Ok...
9noBACKGROUND Hepatocellular carcinoma (HCC) represents the most common primitive liver malignancy. ...
<p>Survival curve for the variables TNM (A), Okuda (B), CLIP (C), GRETCH (D), JIS-AFP-TNM-CHILD (E),...
There are several prognostic systems that address different aspects of the patient and the tumour an...
A major problem in assessing the likelihood of survival of patients with hepatocellular carcinoma (H...
Currently there is no consensus as to which staging system is best in predicting the survival of pat...
A major problem in assessing the likelihood of survival of patients with hepatocellular carcinoma (H...
Many liver staging systems that include the tumor stage and the extent of liver function have been d...
Many liver staging systems that include the tumor stage and the extent of liver function have been d...
The clinical outcome of cirrhotic patients with hepatocellular carcinoma (HCC) depends both on the r...
<p>There was no statistically significant difference in the overall survival rate between caudate HC...
The clinical outcome of cirrhotic patients with hepatocellular carcinoma (HCC) depends both on the r...
Optimal scoring system for clinical prognostic factors in patients with unresectable hepatocellular ...
<p>Stage I versus II, P = .704; stage II versus III, P = .009; stage III Versus IV, P = .000. The di...
<p>Survival Curve of the Studied Sample (n = 247) (A) and overall survival curve of the HCC patients...
<p>Kaplan-Meier survival curves for patients with hepatocellular carcinoma by staging system: (A) Ok...
9noBACKGROUND Hepatocellular carcinoma (HCC) represents the most common primitive liver malignancy. ...
<p>Survival curve for the variables TNM (A), Okuda (B), CLIP (C), GRETCH (D), JIS-AFP-TNM-CHILD (E),...
There are several prognostic systems that address different aspects of the patient and the tumour an...
A major problem in assessing the likelihood of survival of patients with hepatocellular carcinoma (H...
Currently there is no consensus as to which staging system is best in predicting the survival of pat...
A major problem in assessing the likelihood of survival of patients with hepatocellular carcinoma (H...
Many liver staging systems that include the tumor stage and the extent of liver function have been d...
Many liver staging systems that include the tumor stage and the extent of liver function have been d...
The clinical outcome of cirrhotic patients with hepatocellular carcinoma (HCC) depends both on the r...
<p>There was no statistically significant difference in the overall survival rate between caudate HC...
The clinical outcome of cirrhotic patients with hepatocellular carcinoma (HCC) depends both on the r...
Optimal scoring system for clinical prognostic factors in patients with unresectable hepatocellular ...